Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]
Do not use if product is discolored or if precipitate matter is present.
PRECEDEX (dexmedetomidine hydrochloride) injection 200 mcg/2 mL (100 mcg/mL) is clear and colorless. The strength is based on the dexmedetomidine base. Discard unused portion.
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1638-02 | 200 mcg/2 mL |
Tray of 25 single-dose clear glass vials | (100 mcg/mL) |
PRECEDEX (dexmedetomidine hydrochloride in 0.9% Sodium Chloride) injection (4 mcg/mL) is clear and colorless. The strength is based on the dexmedetomidine base. Discard unused portion.
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1660-20 | 80 mcg/20 mL |
Carton of 10 single-dose clear glass vials | (4 mcg/mL) |
NDC 0409-1660-50 | 200 mcg/50 mL |
Tray of 20 single-dose clear glass bottles | (4 mcg/mL) |
NDC 0409-1660-10 | 400 mcg/100 mL |
Tray of 10 single-dose clear glass bottles | (4 mcg/mL) |
NDC 0409-1596-10 Case of 10 cartons containing 1 single-dose clear glass bottle | 400 mcg/100 mL (4 mcg/mL) |
NDC 0409-1434-01 | 1,000 mcg/250 mL |
Carton containing 1 single-dose clear glass bottle | (4 mcg/mL) |
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]
Do not use if product is discolored or if precipitate matter is present.
PRECEDEX (dexmedetomidine hydrochloride) injection 200 mcg/2 mL (100 mcg/mL) is clear and colorless. The strength is based on the dexmedetomidine base. Discard unused portion.
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1638-02 | 200 mcg/2 mL |
Tray of 25 single-dose clear glass vials | (100 mcg/mL) |
PRECEDEX (dexmedetomidine hydrochloride in 0.9% Sodium Chloride) injection (4 mcg/mL) is clear and colorless. The strength is based on the dexmedetomidine base. Discard unused portion.
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1660-20 | 80 mcg/20 mL |
Carton of 10 single-dose clear glass vials | (4 mcg/mL) |
NDC 0409-1660-50 | 200 mcg/50 mL |
Tray of 20 single-dose clear glass bottles | (4 mcg/mL) |
NDC 0409-1660-10 | 400 mcg/100 mL |
Tray of 10 single-dose clear glass bottles | (4 mcg/mL) |
NDC 0409-1596-10 Case of 10 cartons containing 1 single-dose clear glass bottle | 400 mcg/100 mL (4 mcg/mL) |
NDC 0409-1434-01 | 1,000 mcg/250 mL |
Carton containing 1 single-dose clear glass bottle | (4 mcg/mL) |
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.